You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 11, November 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Behavioral Neurology
 •Multiple Sclerosis/ Demyelinating Disease
 •Quality of Life
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Quality of Life Is Not Favorable for Most Patients With Multiple Sclerosis

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We are pleased that the Olmsted County cohort study was able to find that quality of life (QOL) was less adversely affected than studies have found in Canada,1 Norway,2 Spain,3 or the United Kingdom.4 However, there may be methodological reasons why this is the case. The study from Pittock et al5 not only excluded patients with substantial cognitive impairment (itself a major cause of poor QOL for both patients and caregivers),6 but also relied on medical notes for 9 subjects. Medical notes notoriously underreport neuropsychiatric and QOL variables.7 In addition, they used the Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54), which had been criticized owing to questionable validity.8 Strangely, the authors report that 77% of patients were mostly satisfied or delighted, but these are not continuous points on question 54 of the MSQOL, and further, they do not report comparison data from the general population.

Even with these limitations, the . . . [Full Text of this Article]

AUTHOR INFORMATION

Alex J. Mitchell, MB, BS, MRCPsych; Julían Benito-León, MD, PhD; Jesús Rivera-Navarro, PhD; José Manuel Morales-González, MD, PhD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Quality of Life Is Not Favorable for Most Patients With Multiple Sclerosis—Reply
Sean J. Pittock, Robyn L. McClelland, and Moses Rodriguez
Arch Neurol. 2004;61(11):1808.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.